Pharma & Biotech

Breakthrough Discovery Targets Undruggable Cancer Protein, Opening Doors for New Treatments

(IN BRIEF) Researchers have made a significant breakthrough in cancer drug discovery by identifying a new binding site on the…

8 months ago

EIB Supports Universal DX with €20 Million Loan to Advance Early Cancer Detection via Liquid Biopsy

(IN BRIEF) The European Investment Bank (EIB) has signed a €20 million loan agreement with Universal DX, a Spanish startup…

8 months ago

Quest Diagnostics to Acquire Select Assets from Fresenius Medical Care to Enhance Dialysis Services in the U.S.

(IN BRIEF) Quest Diagnostics has agreed to acquire select assets from Fresenius Medical Care’s Spectra Laboratories, expanding its portfolio with…

8 months ago

Sanofi’s Dupixent Receives FDA Priority Review for the Treatment of Bullous Pemphigoid

(IN BRIEF) Sanofi’s Dupixent has been granted FDA priority review for the treatment of bullous pemphigoid (BP), a chronic skin…

8 months ago

Novartis Acquires Anthos Therapeutics to Advance Abelacimab in Stroke and Thrombosis Prevention

(IN BRIEF) Novartis has announced its acquisition of Anthos Therapeutics, a Boston-based biopharmaceutical company focused on developing abelacimab, an investigational…

8 months ago

Patients as Partners® Europe Launches the 9th Annual Event with 2025 Keynotes, Featured Speakers and Topics

(IN BRIEF) The Conference Forum has announced the 9th annual Patients as Partners® Europe event, scheduled for May 20-21, 2025,…

8 months ago